BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32796711)

  • 1. Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy.
    Murray D; Mirzayans R
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinearities in the cellular response to ionizing radiation and the role of p53 therein.
    Murray D; Mirzayans R
    Int J Radiat Biol; 2021; 97(8):1088-1098. PubMed ID: 31986075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.
    Herůdková J; Paruch K; Khirsariya P; Souček K; Krkoška M; Vondálová Blanářová O; Sova P; Kozubík A; Hyršlová Vaculová A
    Neoplasia; 2017 Oct; 19(10):830-841. PubMed ID: 28888100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
    Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
    Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
    Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
    Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicting effects of caffeine on apoptosis and clonogenic survival of human K1 thyroid carcinoma cell lines with different p53 status after exposure to cisplatin or UVc irradiation.
    Deplanque G; Céraline J; Lapouge G; Dufour P; Bergerat JP; Klein-Soyer C
    Biochem Biophys Res Commun; 2004 Feb; 314(4):1100-6. PubMed ID: 14751246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles.
    Asharani PV; Xinyi N; Hande MP; Valiyaveettil S
    Nanomedicine (Lond); 2010 Jan; 5(1):51-64. PubMed ID: 20025464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs.
    Sheridan C; Brumatti G; Elgendy M; Brunet M; Martin SJ
    Oncogene; 2010 Dec; 29(49):6428-41. PubMed ID: 20802529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
    Mirzayans R; Andrais B; Kumar P; Murray D
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells.
    Banerjee K; Mandal M
    Redox Biol; 2015 Aug; 5():153-162. PubMed ID: 25965143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.
    Seluanov A; Gorbunova V; Falcovitz A; Sigal A; Milyavsky M; Zurer I; Shohat G; Goldfinger N; Rotter V
    Mol Cell Biol; 2001 Mar; 21(5):1552-64. PubMed ID: 11238892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of heat-shock protein 70 and P53 proteins in attenuation of UVC-induced apoptosis by thermal stress in hepatocellular carcinoma cells.
    Chen YC; Lin-Shiau SY; Lin JK
    Photochem Photobiol; 1999 Jul; 70(1):78-86. PubMed ID: 10420846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms.
    Gaiddon C; Jeannequin P; Bischoff P; Pfeffer M; Sirlin C; Loeffler JP
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1403-11. PubMed ID: 16169939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis.
    Gupta M; Gupta SK; Balliet AG; Hollander MC; Fornace AJ; Hoffman B; Liebermann DA
    Oncogene; 2005 Nov; 24(48):7170-9. PubMed ID: 16170381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.
    Aroui S; Dardevet L; Ben Ajmia W; de Boisvilliers M; Perrin F; Laajimi A; Boumendjel A; Kenani A; Muller JM; De Waard M
    Mol Pharm; 2015 Dec; 12(12):4336-48. PubMed ID: 26465677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and platinum drugs at the molecular level. (Review).
    Boulikas T; Vougiouka M
    Oncol Rep; 2003; 10(6):1663-82. PubMed ID: 14534679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.
    Pestell KE; Hobbs SM; Titley JC; Kelland LR; Walton MI
    Mol Pharmacol; 2000 Mar; 57(3):503-11. PubMed ID: 10692490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intricatinol synergistically enhances the anticancerous activity of cisplatin in human A549 cells via p38 MAPK/p53 signalling.
    Singh VK; Arora D; Satija NK; Khare P; Roy SK; Sharma PK
    Apoptosis; 2017 Oct; 22(10):1273-1286. PubMed ID: 28756530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2.
    Fedier A; Ruefenacht UB; Schwarz VA; Haller U; Fink D
    Br J Cancer; 2002 Oct; 87(9):1027-33. PubMed ID: 12434296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.